tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medibank Private Announces Cessation of Performance Rights

Story Highlights
Medibank Private Announces Cessation of Performance Rights

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Medibank Private ( (AU:MPL) ) just unveiled an announcement.

Medibank Private Limited announced the cessation of 1,025,688 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.

The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.

More about Medibank Private

Medibank Private Limited operates in the health insurance industry, offering a range of health insurance products and services to individuals and businesses in Australia. The company focuses on providing comprehensive health coverage and related services to enhance the well-being of its customers.

Average Trading Volume: 5,381,255

Technical Sentiment Signal: Buy

Current Market Cap: A$13.74B

See more data about MPL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1